Colorectal
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Metachronous Advanced Neoplasia in Early Onset Colorectal Cancer.
Clinical takeawayNo clinical action yet: this retrospective study does not support altering surveillance intervals for early-onset colorectal cancer (EOCRC) based on MAN risk alone.
What it foundMetachronous advanced neoplasia (MAN) rates were similar in early-onset (13%) and average-onset (16.1%) colorectal cancer patients (p = 0.342).
ContextChallenges the assumption that EOCRC patients require more intensive surveillance than average-onset CRC patients, as MAN rates were comparable.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Naseem Z … Burke CA · American Journal of Gastroenterology · IF 9.8 · PubMed ↗